Corentec Co

Corentec Co Equity Turnover

The Equity Turnover of Corentec Co (104540.KQ) as of Oct 31, 2026 is 1.28. In the previous year, Equity Turnover was 1.30 — a change of -1.51% (lower).

Equity Turnover

1.28

YoY

-1.51%

Last updated:

Equity Turnover of Corentec Co is 2025 1.28 . Equity Turnover of Corentec Co was 2024 1.30 . It decreases by -1.51% lower compared to the previous year.

The Corentec Co Equity Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Turnover
Date
Equity Turnover
Jan 1, 2018
1.39 KRW
Jan 1, 2019
1.34 KRW
Jan 1, 2020
0.87 KRW
Jan 1, 2021
0.79 KRW
Jan 1, 2022
0.97 KRW
Jan 1, 2023
1.25 KRW
Jan 1, 2024
1.30 KRW
Jan 1, 2025
1.28 KRW
The Corentec Co Equity Turnover history
YEAREquity TurnoverYoY
1.28-1.51%
1.30+4.29%
1.25+28.37%
0.97+23.35%
0.79-9.70%
0.87-34.99%
1.34-3.21%
1.39+99.05%
0.70+16.57%
0.60+10.83%
0.54-2.00%
0.55—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corentec Co Stock analysis

What does Corentec Co do? Corentec Co., Ltd. manufactures and sells artificial articulations, including hip, knee, and spine products. The company offers hip products under the BENCOX brand, featuring primary systems, hemi-arthroplasty systems, and revision systems such as cementless femoral stems and acetabular cups. Knee products are sold under the LOSPA brand, including fixed and mobile primary knee systems and revision systems. Spine products also carry the LOSPA IS brand, comprising pedicle screws and peek cages. Corentec distributes these products domestically and internationally, targeting healthcare providers and hospitals that require orthopedic solutions. The firm’s revenue comes from the sale of hip, knee, and spine products through its BENCOX, LOSPA, and LOSPA IS brand portfolios. Domestic and overseas markets are key segments, with the company focusing on orthopedic surgeons and medical institutions that purchase these specialized medical devices. Corentec’s product lines are designed for both primary and revision surgeries, catering to a broad range of orthopedic needs in the healthcare sector. Corentec Co., Ltd. serves healthcare providers globally, with its BENCOX brand dominating hip product sales and LOSPA/LOSPA IS covering knee and spine solutions. The company’s distribution strategy emphasizes direct sales to hospitals and medical centers, ensuring consistent product availability for surgical procedures. By maintaining distinct brand identities for each product category, Corentec efficiently targets specific medical specialties within the orthopedic market. Corentec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corentec Co stock

Equity Turnover of Corentec Co is 1.28 in 2025.

Equity Turnover of Corentec Co changed from 1.30 to 1.28, representing a -1.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Turnover Corentec Co since 2006 – with annual values, charts, and detailed analysis.

Equity turnover measures how efficiently a company uses shareholders' equity to generate revenue. It is a component of the DuPont analysis framework.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Turnover's Corentec Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Equity Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Equity Turnover.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Corentec Co

All Key Metrics — Corentec Co